INSIGHTS ON DRUG DEVELOPMENT
-
Understanding Biotherapeutic Peptides And GLP-1 Receptor Agonists
Biotherapeutic peptides offer enhanced safety and efficacy over traditional drugs. Learn why rigorous impurity profiling is vital to ensure product quality, patient safety, and regulatory compliance.
-
Validating Antibodies With Knock-Out Technologies
Watch to learn about how one company achieves antibody validation through knock-out (KO) technologies as well as the significance of gene KO technologies in the large-scale screening of antibodies.
-
Accelerating Drug Development For Inflammatory Bowel Disease With Organ-Chips
Marianne Kanellias unveils how Emulate's Organ-on-a-Chip technology is revolutionizing the field by enabling a more accurate and complex model of IBD pathogenesis.
-
Next Generation Conjugates: Process And Analytical Challenges
Explore specific examples of challenges commonly encountered in the process and analytical development of next-generation conjugates as well as corresponding solutions for each.
-
Alzheimer's Disease Pathway3/24/2025
Alzheimer’s disease (AD) affects 50 million people globally, causing cognitive decline. Explore the signaling pathways of amyloid beta and tau proteins, linking them to neuronal death and AD symptoms.
-
CDMOs - Key Collaborators In Streamlining Drug Development12/12/2025
Accelerating biologics development requires more than speed. Discover how the right CDMO partnership can streamline processes and help you reach the market faster without sacrificing control.
-
Towards A More Predictive Model Of Human Biology: A Fireside Chat8/2/2024
This presentation explores the implications of the FDA Modernization Act 2.0, the significance of predictive validity in drug discovery, the efficacy of the Emulate human Liver-Chip, and more.
-
Improving Gene Therapy Development With Organ-On-A-Chip Technology8/7/2024
Explore the current challenges of developing gene therapies, the potential of Organ-on-a-Chip technology, the future of gene therapy, and more.
-
Matrix Approach Enhances Potency Assay Development For ATMPs12/22/2025
Potency assays for ATMPs demand precision. Learn how a matrix approach, regulatory alignment, and advanced technologies can overcome variability and ensure safety throughout the product lifecycle.
DRUG DEVELOPMENT SOLUTIONS
-
Gain human-relevant insights with patient-derived assay-ready organoids.
-
Unexpected downtime can drastically impact your organization’s ability to service customers and hinder innovation. With Waters FlexCHOICE: mySystem Coverage*, you can safeguard against lost productivity and unexpected downtime and spend more time on what matters most – your customers and your research.
-
Our team of analytical experts provides experience, efficiency, and technical proficiency in the development/validation of analytical methodology and GMP testing support for your project.
-
Enhance drug solubility and bioavailability with an advanced mesoporous silica excipient that stabilizes poorly soluble compounds in their amorphous form and is backed by strong regulatory and quality support.
-
Examine how sterilizing-grade filters with high flux and broad compatibility support efficient bioprocessing across mAbs, vaccines, and viral vectors.